Cutaneous Leishmaniasis in the Americas: Local or Systemic Treatment? (PAHO 2022)
Decides local or systemic treatment for cutaneous leishmaniasis (PAHO 2022).
Open the tool → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Number of lesions
- 2
- Largest lesion diameter in cm
- 2.5
- Largest lesion area in mm²
- 500
- A lesion on the head or near a joint
- No
- Immunosuppressed
- No
- Follow-up possible
- Yes
- Local treatment failed or relapsed
- No
- Pregnant
- No
- Breastfeeding
- No
- Abnormal ECG
- No
- Weight in kg
- 70
Result: Local treatment fits (1-3 lesions, each 3 cm or less, not on the head or near a joint, not immunosuppressed, follow-up possible): intralesional pentavalent antimony, thermotherapy (50 °C for 30 seconds), or 15% paromomycin cream once a day for 20 days.
The tool opens with these values already filled in. Replace them with your own.
What you enter
- Number of lesions
- Largest lesion diameter in cm
- Largest lesion area in mm² (optional)
- A lesion on the head or near a joint
- Immunosuppressed
- Follow-up possible
- Local treatment failed or relapsed
- Pregnant
- Breastfeeding
- Abnormal ECG
- Weight in kg (for systemic doses)
How this is calculated
Citation
Pan American Health Organization. Guideline for the treatment of leishmaniasis in the Americas. 2nd ed. Washington, DC: PAHO; 2022. Tables 2-4 (pp. 57-62). Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.